Introduction: The incidence and prevalence of sexual problems and sexual dysfunction among people living with cancer is high. Evidence suggests that sexual dysfunction is a threat to the joy of life and marital relationships, and can lead to stress and impaired coping ability in chronic ill patients. Yet, sexuality is still a neglected topic among health professionals. Objectives: To increase oncology and haematology nurses awareness, knowledge and skills about patients with cancer's specific and general sexual problems and how to approach an interview, where the theme is sexuality after cancer treatment. Methods: Academic Society for Cancer Nurses (FSK) has taken the initiative to form a Danish national working group in 2015 to develop and implement a national intervention with the above objectives. The effect of the intervention is evaluated by a national survey about nurses' knowledge and skills in relation to sexuality in patients with cancer. The intervention is aimed at patients living with cancer regardless of sexual orientation or sexual partner. Results: The details of the national intervention is expected to be finished by 1/5 2015. Conclusions: The patient's individual needs should be identified through initiation of conversations regarding sexual dysfunction in the medical setting. These conversations can help normalize concerns for patients, debunk myths, provide a basis for brief counselling or serve as an entree for a referral. Sexual function is an important aspect of life and should be placed on par with discussions of the disease, its treatment, and other symptoms or complications by health professionals.
Supportive Care in Cancer, 2015, Vol 23, Issue 1 Supplement
*human *neoplasm *nurse *patient *skill *sexuality *hematology *oncology sexual dysfunction conversation health practitioner prevalence sexual orientation society cancer therapy interview sexual function literature counseling coping behavior; *hospital infection *neoplasm human patient oncology ward infection ward risk urinary tract diarrhea disease control bacteremia safety health care pneumonia serum hospitalization infection control surgical ward mouth hygiene prevention immune system; *hospital *neoplasm pathogen load microorganism microbiology colony forming unit hospital infection photometer oncology ward *adenosine triphosphate marker; *salivary gland function *radiation dose *salivary gland *radiotherapy *head and neck cancer *neoplasm salivation xerostomia stimulus chewing gum radiotherapy planning system side effect flow rate questionnaire prescription drug megadose human patient submandibular gland pilot study food saliva sugar; *central venous catheter *bloodstream infection *therapy *acute lymphoblastic leukemia *cohort analysis *Denmark *neoplasm human patient risk child attributable risk diagnosis death pediatric hospital confidence interval population high risk population neutropenia Gram positive infection; *febrile neutropenia *cancer patient *human *neoplasm male female chemotherapy patient cerebrospinal fluid drug dose reduction risk aged prostate diagnosis Denmark prospective study ovary cancer university hospital oncology retrospective study density prognosis adverse drug reaction *granulocyte colony stimulating factor; *head and neck cancer *radiation *neoplasm mucosa inflammation risk proportional hazards model acceleration human regression analysis log rank test patient radiotherapy intensity modulated radiation therapy; *human *phase 1 clinical trial *neoplasm *patient *rectum cancer *neuropathy *prevention neurotoxicity chemotherapy allodynia infusion peripheral neuropathy safety phase 2 clinical trial antineoplastic activity adverse drug reaction model toxicity experience controlled study *placebo oxaliplatin fluorouracil protective agent; *myeloma *patient *human *neoplasm survival morbidity death kidney failure diagnosis scoring system quality of life hope disease severity infection; *rehabilitation *cancer patient *human *neoplasm rehabilitation center patient heart disease quality of life cardiac patient solid mortality learning hospitalization diagnosis economic aspect cancer survivor; *osteoporosis *chemotherapy *breast cancer *neoplasm *risk human patient osteolysis hip spine adjuvant chemotherapy secondary osteoporosis radius bone density Fisher exact test cohort analysis drug therapy fracture cancer patient forearm absorptiometry X ray imaging cancer chemotherapy prednisolone corticosteroid marker calcium vitamin D; *hypothyroidism *radiotherapy *neoplasm thyroid gland neck human patient risk factor surgery radiation radiation dose planning model chemotherapy breast cancer subclinical hypothyroidism Hodgkin disease head and neck squamous cell carcinoma data extraction treatment planning thyroid function risk prediction tissues; *overall survival *patient *human *neoplasm *Charlson Comorbidity Index stereotactic body radiation therapy comorbidity lung cancer non small cell lung cancer scoring system medical record review physician survival control group histology gender follow up smoking tumor volume data base; *neoplasm *risk human chemotherapy quality of life cancer survivor prevention single nucleotide polymorphism peripheral neuropathy predictive value side effect genomics glove detoxification genotype gene DNA repair genetic variability patient toxicity platinum derivative enzyme DNA; *radiotherapy *cohort analysis *larynx cancer *cancer patient *human *neoplasm *tobacco use smoking lowest income group diagnosis statistics head and neck cancer data base diseases tobacco primary tumor treatment response prognosis logistic regression analysis Denmark risk tobacco consumption patient world health organization; *human *cancer patient *neoplasm *spouse *radiotherapy *head and neck cancer patient diseases physician child friend hospital memory nutrition information processing; *overall survival *radiotherapy *non small cell lung cancer *neoplasm human patient survival radiation chemotherapy histology lung function thorax tumor squamous cell carcinoma lung cancer gender world health organization; *neoplasm *human *vein thrombosis *patient thrombosis cancer patient risk questionnaire morbidity lung cancer cancer prevention death male prevention female; *side effect *human *retrospective study *neoplasm *eye disease patient eye non small cell lung cancer tear flow blurred vision conjunctivitis Denmark oncology toxicity quality of life university hospital clinical practice dry eye palliative therapy swelling skin *pemetrexed; *rehabilitation *interview *oncology ward *nursing *neoplasm human nurse patient intuition hospitalization oral communication hematology ward skill oncology verbal communication communication skill nursing competence questionnaire interpersonal communication
Main Research Area:
The MASCC/ISOO Annual Meeting on Supportive Care in Cancer, 2015